by investoropportunity | Sep 22, 2024 | Company Research, Energy, Home Page Feature Articles, Mining, Technology
A world class hydrogen asset in the making. The level of interest from large industry players now following QI Materials’ hydrogen exploration efforts is significant. Chances are QIMC will not exist in a year or so as with every positive news release it increasingly...
by investoropportunity | Apr 30, 2024 | Company Research, Home Page Feature Articles
According to the Centers for Medicare and Medicaid Services, Americans spent $4.4 trillion on healthcare in 2022, ~$3 trillion of this spending flowed through health insurance companies. Healthcare spending is forecast to top $7 trillion in 2031. What makes Oscar...
by investoropportunity | Nov 29, 2023 | Uncategorized
Market Equities Research Group has a near-term (12 month) share price target several times the current for CSE:QIMC: QIMC currently has a nominal market cap of ~C$2.3M (~73.91 million shares trading near ~C$0.03). With proven reliable high-purity silica assets, and a...
by investoropportunity | Nov 17, 2023 | Uncategorized
Québec Nickel Corp. (CSE: QNI) (OTCQB: QNICF) (Frankfurt: 71B) currently has a 5000 m drill program underway along footwall contact at Fortin Zone to discover more high-grade Ni-Cu-Co-PGE-Au pockets. QNI currently has a nominal market cap of ~C$3.5M (~115.34 million...
by investoropportunity | Mar 15, 2023 | Company Research, Health, Home Page Feature Articles, Technology, Uncategorized
PharmAla is the first for-profit company to synthesize clinical-grade (GMP) MDMA and make it available for sale to both researchers and qualified patients. PharmAla will increasingly develop a target on its back for acquisition and we expect a rise in marketcap via...
Recent Comments